Executive resigns

Quote

anonymous

Guest
What's going on with this company? I heard that your executives are bailing. The Chief medical Officer resigned, the CTO wants to quit and the founders have started selling stick as soon as the lock up expired. Anyone care to tell me why I should stick around?
 



anonymous said:
What's going on with this company? I heard that your executives are bailing. The Chief medical Officer resigned, the CTO wants to quit and the founders have started selling stick as soon as the lock up expired. Anyone care to tell me why I should stick around?
Click to expand...

You're a troll...people move on, it's life. The CMO has plenty of stake in the company still. Doesn't need or want the responsibility and needs to spend more time with family. Founders aren't selling shit, stock holding steady, actually slight 3M increase...you know nothing
 






anonymous said:
Hey, KS's resident cheerleader is back. And lying again. Founders are selling as soon as they can: http://www.insidertradingreport.org...atthew-rabinowitz-sells-83804-shares/6210587/

"Spending time with family". You need to smell your own BS, d-bag.
Click to expand...

Wow, he sold 83k shares...so much...do you know how many shares he owns and how much money he has? Maybe he did it for tax purposes....who knows..you certainly don't. Make a big deal out of nothing. That link actually shows some positives for the share price if you read beyond the headline...that would require you to read though...wouldn't spect that..
 



Both founders have been selling stock the past week, as soon as they had a chance to. It certainly shows a lack of belief in the share price (although not the company). There better not be bad news in the Q1 results.
 



While I agree that the company is going to shit, only a complete rookie will look at Form 4 data and make judgements off of that. This is obviously your first rodeo, cowboy.
 



How's it feel now, cowboy? Founders have been selling shares and raking in the millions while layoffs are announced! Still believe in the executive team's leadership? Maybe you should ask them for some extra cake while you are on your knees.
 



anonymous said:
You're a troll...people move on, it's life. The CMO has plenty of stake in the company still. Doesn't need or want the responsibility and needs to spend more time with family. Founders aren't selling shit, stock holding steady, actually slight 3M increase...you know nothing
Click to expand...

According to management and their cheerleader allies........no matter what happens it's always our fault. By default, they simply tell me....Well, I'm sure you saw the writing on the wall.
 



anonymous said:
You're a troll...people move on, it's life. The CMO has plenty of stake in the company still. Doesn't need or want the responsibility and needs to spend more time with family. Founders aren't selling shit, stock holding steady, actually slight 3M increase...you know nothing
Click to expand...

Guess our ex-CMO didn't have faith in our oncology pipeline...

Provista Diagnostics Appoints Susan Gross, M.D., as Chief Medical Officer
NEW YORK, NY – March 1, 2016 – Provista Diagnostics Inc., a company developing and commercializing proteomic-based diagnostic, prognostic and monitoring tests for cancers affecting women, has appointed Susan Gross, M.D., as Chief Medical Officer. In this role, Dr. Gross will oversee and guide the continued clinical progress of the company’s pipeline diagnostics and identify new diagnostic approaches for development.

Dr. Gross is a renowned expert in women’s health and diagnostics and is recognized for her work in the development of commercially available screening tests used in prenatal care settings. She is a professor of Clinical Obstetrics & Gynecology and Women’s Health, Pediatrics and Genetics at the Albert Einstein College of Medicine in New York City, and she has contributed to national guideline and policy development.

“Dr. Gross’ expertise and track record will be an invaluable asset in Provista’s work to deliver diagnostic technologies that close important clinical gaps and serve women’s health needs,” said David E. Reese, Ph.D., President and Chief Executive Officer, Provista Diagnostics Inc. “Dr. Gross will provide critical leadership in the year ahead as we advance our clinical development programs and look toward sharing the results of multiple clinical research studies on our lead diagnostic test, Videssa® Breast.”

Dr. Gross joins Provista from Natera where she served as the Chief Medical Officer, overseeing the development of the company’s prenatal screening tests. Dr. Gross is also the founding director of Einstein’s Program for Jewish Genetic Health and founder of the Human Genetics Laboratory at Jacobi Medical Center, which was developed to provide underserved women with equal access to state-of-the-art prenatal genetic services.

“The opportunity to advance Provista’s novel pipeline of diagnostics aligns perfectly with my passion for advancing the health and well-being of women,” Dr. Gross said. “As Chief Medical Officer of Provista, my work will contribute to an important objective – developing the diagnostics needed to catch cancers earlier – and provide both clinicians and patients accurate information to make informed treatment decisions, with greater confidence and clarity.”
 



anonymous said:
Guess our ex-CMO didn't have faith in our oncology pipeline...

Provista Diagnostics Appoints Susan Gross, M.D., as Chief Medical Officer
NEW YORK, NY – March 1, 2016 – Provista Diagnostics Inc., a company developing and commercializing proteomic-based diagnostic, prognostic and monitoring tests for cancers affecting women, has appointed Susan Gross, M.D., as Chief Medical Officer. In this role, Dr. Gross will oversee and guide the continued clinical progress of the company’s pipeline diagnostics and identify new diagnostic approaches for development.

Dr. Gross is a renowned expert in women’s health and diagnostics and is recognized for her work in the development of commercially available screening tests used in prenatal care settings. She is a professor of Clinical Obstetrics & Gynecology and Women’s Health, Pediatrics and Genetics at the Albert Einstein College of Medicine in New York City, and she has contributed to national guideline and policy development.

“Dr. Gross’ expertise and track record will be an invaluable asset in Provista’s work to deliver diagnostic technologies that close important clinical gaps and serve women’s health needs,” said David E. Reese, Ph.D., President and Chief Executive Officer, Provista Diagnostics Inc. “Dr. Gross will provide critical leadership in the year ahead as we advance our clinical development programs and look toward sharing the results of multiple clinical research studies on our lead diagnostic test, Videssa® Breast.”

Dr. Gross joins Provista from Natera where she served as the Chief Medical Officer, overseeing the development of the company’s prenatal screening tests. Dr. Gross is also the founding director of Einstein’s Program for Jewish Genetic Health and founder of the Human Genetics Laboratory at Jacobi Medical Center, which was developed to provide underserved women with equal access to state-of-the-art prenatal genetic services.

“The opportunity to advance Provista’s novel pipeline of diagnostics aligns perfectly with my passion for advancing the health and well-being of women,” Dr. Gross said. “As Chief Medical Officer of Provista, my work will contribute to an important objective – developing the diagnostics needed to catch cancers earlier – and provide both clinicians and patients accurate information to make informed treatment decisions, with greater confidence and clarity.”
Click to expand...

mouth drops....
 









Top Bottom
Back
Quote